Stem Cells

• Cardiovascular Diseases

Stem Cells Infusion Reduced HF Risk in AMI

Intracoronary infusion of Wharton’s jelly–derived mesenchymal stem cells after acute myocardial infarction (AMI) significantly reduced the risk of developing heart…